PlexusDx vs Gimme Health: Tirzepatide Pricing and Evidence Compared

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Gimme Health's reported tirzepatide injection price of $199/month is lower than PlexusDx's $289 month-to-month or $249 six-month rate. However, the $199 figure originates from a Reddit user report captured September 4, 2026, and was not verified at checkout. No primary pricing page, multi-month options, refill pricing, or service inclusions (visits, labs, shipping) were documented for Gimme. PlexusDx publishes checkout-verified pricing, states all inclusions up front, and offers three commitment tiers with the same price at every dose. If you need transparent, documented terms and verifiable pricing, PlexusDx provides that. If Gimme's reported rate holds at checkout and its undocumented service model meets your needs, it may offer a lower monthly cost—but you must confirm price, inclusions, cancellation terms, and pharmacy accreditation directly with Gimme before committing.

At-a-glance comparison

Tirzepatide pricing: reported vs verified

Gimme Health's $199/month tirzepatide injection figure appeared in a Reddit user report captured September 4, 2026. The research team checked Gimme's website (gimmehealth.com) but found no indexed primary pricing page, no checkout flow available for verification, and no documentation of refill pricing or multi-month commitment options. The dataset notes explicitly: "Evidence: Secondary" and "Primary checkout verification required." As a result, the $199 rate is an individual user's report, not a confirmed checkout price, and we cannot verify whether it represents an introductory rate, a standard ongoing rate, or includes all service components.

PlexusDx publishes checkout-verified tirzepatide injection pricing in three tiers:

• Month-to-month: $289/month, billed monthly, no commitment.
• 3-month commitment: $269/month (calculated prepaid equivalent: $807 charged every three months).
• 6-month commitment: $249/month (calculated prepaid equivalent: $1,494 charged every six months).

All PlexusDx tirzepatide rates include the compounded medication, a provider visit for prescription review, and shipping to your door. The same price applies at every dose—2.5 mg, 5 mg, 7.5 mg, or higher—so cost does not increase as your clinician titrates upward.

12-month cost comparison

The table below shows the total cost of tirzepatide injection over 12 months under each plan. Gimme's calculation uses the reported $199/month figure; PlexusDx figures are checkout-verified. Both calculations are ours.

If Gimme's reported $199 rate proves accurate at checkout and applies to all refills without hidden fees, the 12-month cost would be $2,388—$1,080 less than PlexusDx month-to-month and $600 less than PlexusDx's six-month prepaid rate (our calculations). PlexusDx's month-to-month rate is $90/month higher than Gimme's reported figure; the six-month prepaid rate is $50/month higher.

However, the cost advantage depends entirely on whether the $199 figure is complete (medication, visits, shipping, no membership) and remains consistent after the first fill. The evidence does not answer those questions.

What the evidence gap means for decision-making

Gimme Health's lower reported monthly rate is appealing on its face, but the evidence gap introduces uncertainty that may matter more than the dollar difference:

• No checkout verification. The $199 figure was reported by one Reddit user and was not confirmed in a checkout flow. We do not know if it applies to first fills only, all refills, or remains current as of September 2026.
• No documented inclusions. The dataset notes "Inclusions: Not independently verified; inclusions unknown." It is unclear whether $199 covers provider visits, shipping, or ongoing clinical support, or whether those carry separate fees.
• No multi-month terms. Gimme may offer prepaid discounts similar to PlexusDx's three- and six-month options, but no such plans were documented.
• No refund or cancellation policy. If you enroll and the medication is not appropriate, or if supply is interrupted, the terms governing refunds or early cancellation are not publicly available.
• No indexed pricing page. Gimme's website was checked September 4, 2026, and no current pricing page was found, making pre-enrollment price comparison difficult.
• No review record. Gimme has no Trustpilot profile, and Reddit search yielded one reference thread with no coded service themes. There is no independent quality or reliability signal.

By contrast, PlexusDx publishes checkout-verified pricing, states that medication, provider access, and shipping are included in every tier, and holds a 4.3-star Trustpilot rating with 83% of reviews at four stars or higher (captured September 9, 2026). The prepaid six-month rate narrows the cost gap to $50/month (our calculation) while providing documented terms and verifiable service inclusions.

Dose titration and cost predictability

Tirzepatide treatment typically begins at 2.5 mg weekly and titrates upward every four weeks—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg—based on tolerance and response. Some telehealth providers charge more at higher doses, so a patient's cost doubles or triples as the clinician increases the prescription.

PlexusDx charges the same rate at every dose. A patient starting at 2.5 mg and titrating to 10 mg pays $289/month (month-to-month) or $249/month (six-month prepaid) throughout, with no surprise increases. Gimme's dose policy is not documented, so it is unknown whether the reported $199 rate applies uniformly across the dose range or changes as titration progresses.

Transparency and pharmacy accreditation

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Because the medication is prepared by a compounding pharmacy rather than a commercial manufacturer, the pharmacy's regulatory standing and quality controls become critical decision factors. PlexusDx states publicly that it works with licensed 503A compounding pharmacies, which operate under state boards of pharmacy and are subject to regular inspection. Gimme's pharmacy partnerships and accreditation status are not documented in the evidence. Before enrolling with any compounded-medication provider, confirm that the dispensing pharmacy is a licensed 503A facility and verify its inspection history with the relevant state board.

Choose Gimme Health if…

• You confirm at checkout that the $199/month rate is accurate, applies to all refills, and includes medication, visits, and shipping with no separate membership or per-visit fees.
• You verify that Gimme works with licensed 503A compounding pharmacies and that the dispensing pharmacy has a clean inspection record.
• You obtain and review the cancellation and refund policy before enrollment, and those terms meet your needs.
• You are comfortable proceeding without an independent service-quality signal (no Trustpilot reviews or documented user feedback).
• The lower reported monthly cost outweighs the value of checkout-verified pricing and documented inclusions.

Choose PlexusDx if…

• You want tirzepatide pricing verified at checkout, with no secondary-source uncertainty about what the rate includes or whether it changes after the first fill.
• You want transparent inclusions—medication, provider visit, and shipping stated up front with no hidden fees.
• You value cost predictability across dose titration: the same monthly rate whether your clinician prescribes 2.5 mg or 15 mg.
• You want the flexibility of three commitment tiers, including a six-month prepaid option that narrows the cost gap to $50/month compared to Gimme's reported rate (our calculation).
• You want documented pharmacy partnerships (licensed 503A facilities) and a provider with an established review record (4.3 stars on Trustpilot, 83% four stars or higher, captured September 9, 2026).
• You want refund, cancellation, and prescribing policies stated clearly before you start your intake.

Methodology and freshness

This comparison uses pricing and service data captured September 4–6, 2026. Gimme Health's $199/month tirzepatide figure originates from a Reddit user report captured September 4, 2026; the research team checked gimmehealth.com but found no indexed primary pricing page and completed no checkout verification. Gimme's inclusions, multi-month options, refund terms, and pharmacy accreditation are marked "not documented" in the dataset. PlexusDx pricing ($289 month-to-month, $269 three-month, $249 six-month for tirzepatide injection) is checkout-verified as of September 6, 2026. The 12-month cost calculations and prepaid monthly-equivalent figures are ours. Trustpilot ratings for PlexusDx (4.3 stars, 83% four stars or higher) were captured September 9, 2026; no Gimme Trustpilot profile was located. Readers should confirm all Gimme pricing, inclusions, pharmacy partnerships, and terms directly at checkout before enrollment.

Frequently Asked Questions

Is Gimme Health's $199/month tirzepatide price verified?

No. The $199 figure comes from a Reddit user report captured September 4, 2026. The research team found no primary pricing page on Gimme's website and completed no checkout verification. Confirm the rate, inclusions, and whether it applies to all refills directly with Gimme before enrolling.

Does PlexusDx charge more when my tirzepatide dose increases?

No. PlexusDx charges the same rate at every dose—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg. If your clinician titrates your prescription upward, your monthly cost remains $289 (month-to-month), $269 (three-month prepaid), or $249 (six-month prepaid) throughout treatment.

What does PlexusDx's tirzepatide price include?

The monthly rate includes compounded tirzepatide injection medication, a provider visit for prescription review and approval, and shipping to your address. There is no separate membership fee, no per-visit charge, and no lab fee unless follow-up lab work is clinically indicated and you opt in.

How much can I save with PlexusDx's six-month prepaid plan?

The six-month commitment reduces the effective monthly rate from $289 to $249—a saving of $40/month or $480 over six months (our calculation). You pay $1,494 upfront every six months. The rate remains $249/month at every dose throughout the commitment period.

Are compounded tirzepatide and brand-name Zepbound the same?

No. Compounded tirzepatide is not FDA-approved and is not the same as brand-name Zepbound (tirzepatide). FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a compounded prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Sources

• PlexusDx tirzepatide injection pricing and inclusions, accessed September 6, 2026.
• Gimme Health tirzepatide pricing (Reddit user report), captured September 4, 2026.
• Gimme Health website (gimmehealth.com), checked for primary pricing page September 4, 2026.
• PlexusDx Trustpilot rating (4.3 stars, 83% four stars or higher), captured September 9, 2026.
• Trustpilot search for Gimme Health, no profile located, captured September 4, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.